A citation-based method for searching scientific literature

Darrick T Balu, Yan Li, Matthew D Puhl, Michael A Benneyworth, Alo C Basu, Shunsuke Takagi, Vadim Y Bolshakov, Joseph T Coyle. Proc Natl Acad Sci U S A 2013
Times Cited: 149







List of co-cited articles
1201 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior.
A C Basu, G E Tsai, C-L Ma, J T Ehmsen, A K Mustafa, L Han, Z I Jiang, M A Benneyworth, M P Froimowitz, N Lange,[...]. Mol Psychiatry 2009
223
37

Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists.
Thomas Papouin, Laurent Ladépêche, Jérôme Ruel, Silvia Sacchi, Marilyne Labasque, Marwa Hanini, Laurent Groc, Loredano Pollegioni, Jean-Pierre Mothet, Stéphane H R Oliet. Cell 2012
464
30


D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor.
J P Mothet, A T Parent, H Wolosker, R O Brady, D J Linden, C D Ferris, M A Rogawski, S H Snyder. Proc Natl Acad Sci U S A 2000
866
25


A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia.
Inna Bendikov, Carmit Nadri, Shirly Amar, Rogerio Panizzutti, Joari De Miranda, Herman Wolosker, Galila Agam. Schizophr Res 2007
245
24

Serine racemase is predominantly localized in neurons in mouse brain.
Kazushi Miya, Ran Inoue, Yoshimi Takata, Manabu Abe, Rie Natsume, Kenji Sakimura, Kazuhisa Hongou, Toshio Miyawaki, Hisashi Mori. J Comp Neurol 2008
184
23

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
J H Krystal, L P Karper, J P Seibyl, G K Freeman, R Delaney, J D Bremner, G R Heninger, M B Bowers, D S Charney. Arch Gen Psychiatry 1994
21


The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex.
Darrick T Balu, Alo C Basu, John P Corradi, Angela M Cacace, Joseph T Coyle. Neurobiol Dis 2012
65
30

The Rise and Fall of the d-Serine-Mediated Gliotransmission Hypothesis.
Herman Wolosker, Darrick T Balu, Joseph T Coyle. Trends Neurosci 2016
111
20

D-serine and serine racemase are localized to neurons in the adult mouse and human forebrain.
Darrick T Balu, Shunsuke Takagi, Matthew D Puhl, Michael A Benneyworth, Joseph T Coyle. Cell Mol Neurobiol 2014
79
24


Cell selective conditional null mutations of serine racemase demonstrate a predominate localization in cortical glutamatergic neurons.
Michael A Benneyworth, Yan Li, Alo C Basu, Vadim Y Bolshakov, Joseph T Coyle. Cell Mol Neurobiol 2012
101
18

Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion.
T M Ma, S Abazyan, B Abazyan, J Nomura, C Yang, S Seshadri, A Sawa, S H Snyder, M V Pletnikov. Mol Psychiatry 2013
112
17

Recent advances in the phencyclidine model of schizophrenia.
D C Javitt, S R Zukin. Am J Psychiatry 1991
17

D-serine added to antipsychotics for the treatment of schizophrenia.
G Tsai, P Yang, L C Chung, N Lange, J T Coyle. Biol Psychiatry 1998
511
17

Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model.
Viviane Labrie, Ryutaro Fukumura, Anjali Rastogi, Laura J Fick, Wei Wang, Paul C Boutros, James L Kennedy, Mawahib O Semeralul, Frankie H Lee, Glen B Baker,[...]. Hum Mol Genet 2009
132
16


Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology.
L M DeVito, D T Balu, B R Kanter, C Lykken, A C Basu, J T Coyle, H Eichenbaum. Genes Brain Behav 2011
85
16


Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.
Kenji Hashimoto, Takeshi Fukushima, Eiji Shimizu, Naoya Komatsu, Hiroyuki Watanabe, Naoyuki Shinoda, Michiko Nakazato, Chikara Kumakiri, Shin-ichi Okada, Hisanori Hasegawa,[...]. Arch Gen Psychiatry 2003
383
14

A genetic variant of the serine racemase gene is associated with schizophrenia.
Yukitaka Morita, Hiroshi Ujike, Yuji Tanaka, Kyohei Otani, Makiko Kishimoto, Akiko Morio, Tatsuya Kotaka, Yuko Okahisa, Masayuki Matsushita, Akiko Morikawa,[...]. Biol Psychiatry 2007
78
16

Identity of endogenous NMDAR glycine site agonist in amygdala is determined by synaptic activity level.
Yan Li, Silvia Sacchi, Loredano Pollegioni, Alo C Basu, Joseph T Coyle, Vadim Y Bolshakov. Nat Commun 2013
57
22


Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients.
Kenji Hashimoto, Göran Engberg, Eiji Shimizu, Conny Nordin, Leif H Lindström, Masaomi Iyo. Prog Neuropsychopharmacol Biol Psychiatry 2005
197
13

Neuronal D-serine and glycine release via the Asc-1 transporter regulates NMDA receptor-dependent synaptic activity.
Dina Rosenberg, Samar Artoul, Adi C Segal, Goren Kolodney, Inna Radzishevsky, Elena Dikopoltsev, Veronika N Foltyn, Ran Inoue, Hisashi Mori, Jean-Marie Billard,[...]. J Neurosci 2013
150
13

The presence of free D-serine in rat brain.
A Hashimoto, T Nishikawa, T Hayashi, N Fujii, K Harada, T Oka, K Takahashi. FEBS Lett 1992
341
13

Identity of the NMDA receptor coagonist is synapse specific and developmentally regulated in the hippocampus.
Matildé Le Bail, Magalie Martineau, Silvia Sacchi, Natalia Yatsenko, Inna Radzishevsky, Sandrine Conrod, Karima Ait Ouares, Herman Wolosker, Loredano Pollegioni, Jean-Marie Billard,[...]. Proc Natl Acad Sci U S A 2015
77
15

D-serine in glia and neurons derives from 3-phosphoglycerate dehydrogenase.
Jeffrey T Ehmsen, Ting Martin Ma, Hagit Sason, Dina Rosenberg, Tadashi Ogo, Shigeki Furuya, Solomon H Snyder, Herman Wolosker. J Neurosci 2013
74
16


Glia-derived D-serine controls NMDA receptor activity and synaptic memory.
Aude Panatier, Dionysia T Theodosis, Jean-Pierre Mothet, Bastien Touquet, Loredano Pollegioni, Dominique A Poulain, Stéphane H R Oliet. Cell 2006
624
12


Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia.
Ilya Chumakov, Marta Blumenfeld, Oxana Guerassimenko, Laurent Cavarec, Marta Palicio, Hadi Abderrahim, Lydie Bougueleret, Caroline Barry, Hiroaki Tanaka, Philippe La Rosa,[...]. Proc Natl Acad Sci U S A 2002
631
12

D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis.
Jumpei Sasabe, Tomohiro Chiba, Marina Yamada, Koichi Okamoto, Ikuo Nishimoto, Masaaki Matsuoka, Sadakazu Aiso. EMBO J 2007
193
12

The neurobiology of D-amino acid oxidase and its involvement in schizophrenia.
L Verrall, P W J Burnet, J F Betts, P J Harrison. Mol Psychiatry 2010
123
12

NMDA- and beta-amyloid1-42-induced neurotoxicity is attenuated in serine racemase knock-out mice.
Ran Inoue, Kenji Hashimoto, Tomomi Harai, Hisashi Mori. J Neurosci 2008
127
12

Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide.
Sheng-Zhou Wu, Angela M Bodles, Mandy M Porter, W Sue T Griffin, Anthony S Basile, Steven W Barger. J Neuroinflammation 2004
154
12

D-Serine and Serine Racemase Are Associated with PSD-95 and Glutamatergic Synapse Stability.
Hong Lin, Ariel A Jacobi, Stewart A Anderson, David R Lynch. Front Cell Neurosci 2016
35
34

Purification of serine racemase: biosynthesis of the neuromodulator D-serine.
H Wolosker, K N Sheth, M Takahashi, J P Mothet, R O Brady, C D Ferris, S H Snyder. Proc Natl Acad Sci U S A 1999
398
12



Long-term potentiation depends on release of D-serine from astrocytes.
Christian Henneberger, Thomas Papouin, Stéphane H R Oliet, Dmitri A Rusakov. Nature 2010
875
11

Serine racemase deletion protects against cerebral ischemia and excitotoxicity.
Asif K Mustafa, Abdullah S Ahmad, Emil Zeynalov, Sadia K Gazi, Gautam Sikka, Jeffrey T Ehmsen, Roxanne K Barrow, Joseph T Coyle, Solomon H Snyder, Sylvain Doré. J Neurosci 2010
76
14

High dose D-serine in the treatment of schizophrenia.
Joshua T Kantrowitz, Anil K Malhotra, Barbara Cornblatt, Gail Silipo, Andrea Balla, Raymond F Suckow, Cyril D'Souza, John Saksa, Scott W Woods, Daniel C Javitt. Schizophr Res 2010
160
11

Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor.
Hsien-Yuan Lane, Ching-Hua Lin, Michael F Green, Gerhard Hellemann, Chih-Chia Huang, Po-Wei Chen, Rene Tun, Yue-Cung Chang, Guochuan E Tsai. JAMA Psychiatry 2013
143
11

Serine racemase modulates intracellular D-serine levels through an alpha,beta-elimination activity.
Veronika N Foltyn, Inna Bendikov, Joari De Miranda, Rogerio Panizzutti, Elena Dumin, Maria Shleper, Pu Li, Michael D Toney, Elena Kartvelishvily, Herman Wolosker. J Biol Chem 2005
164
11


De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia.
G Kirov, A J Pocklington, P Holmans, D Ivanov, M Ikeda, D Ruderfer, J Moran, K Chambert, D Toncheva, L Georgieva,[...]. Mol Psychiatry 2012
558
10

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.
Pierre Paoletti, Camilla Bellone, Qiang Zhou. Nat Rev Neurosci 2013
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.